LEO Pharma appeared to be the Corporate Investor, which was created in 1908. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Parsippany.
The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2018. The fund is constantly included in less than 2 deals per year. The real fund results show that this Corporate Investor is 80 percentage points more often commits exit comparing to other companies.
This organization was formed by August Kongsted.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the LEO Pharma, startups are often financed by LEO Innovation Lab, BridgeBio. In the next rounds fund is usually obtained by LEO Innovation Lab.
Among the most popular portfolio startups of the fund, we may highlight PellePharm. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
|Christopher Toomey Trust||-|
|Coinsilium Group||England, London, United Kingdom|
|Dongguan Ione Electronic||China, Dongguang, Guangdong|
|Endeavour Ventures||England, London, United Kingdom|
|First National Bank Of Omaha||Nebraska, Omaha, United States|
|ForgeHealth||Atlanta, Georgia, United States|
|Fujisan Magazine Service||Japan, Kanagawa Prefecture, Kawasaki|
|iMinds||Belgium, Ghent, Oost-Vlaanderen|
|ITX Corporation||New York, Pittsford, United States|
|Jurisweb Interactiva||Barcelona, Catalonia, Spain|
|Motianshi Touzi||China, Guangdong, Guangzhou|
|New Zealand Growth Capital Partners||-|
|NPO Nauka PAO||Moscow, Moscow, Russia|
|Sagamore Ventures||Baltimore, Maryland, United States|
|Startupbootcamp FinTech Singapore||Central, Central Region, Singapore|
|Tianxun Capital||China, Hunan, Liuyang|
|Watrium AS||Norway, Oslo|
|$7M||30 Jul 2018||North Holland|
|01 Mar 2018||Capital Region of Denmark|
|$3M||10 Jul 2015||North Holland|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.